Paper36968995
The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives.
Gargiulo E and 5 others. Front Oncol, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives. Papers, record 36968995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36968995
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References114
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26086440 | Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells. | PLoS One | 2015 | https://conductscience.org/library/papers/26086440 | PubMed |
| 2 | 2920210 | High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. | Blood | 1989 | https://conductscience.org/library/papers/2920210 | PubMed |
| 3 | 32319019 | Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond. | Target Oncol | 2020 | https://conductscience.org/library/papers/32319019 | PubMed |
| 4 | 24871132 | Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/24871132 | PubMed |
| 5 | 28983798 | Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience. | Adv Ther | 2017 | https://conductscience.org/library/papers/28983798 | PubMed |
| 6 | 11830482 | Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides. | Blood | 2002 | https://conductscience.org/library/papers/11830482 | PubMed |
| 7 | 21368287 | Evidence of canonical somatic hypermutation in hairy cell leukemia. | Blood | 2011 | https://conductscience.org/library/papers/21368287 | PubMed |
| 8 | 35930750 | Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy. | Blood | 2022 | https://conductscience.org/library/papers/35930750 | PubMed |
| 9 | 21403646 | CD40 stimulation sensitizes CLL cells to rituximab-induced cell death. | Leukemia | 2011 | https://conductscience.org/library/papers/21403646 | PubMed |
| 10 | 33771887 | A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity. | Sci Immunol | 2021 | https://conductscience.org/library/papers/33771887 | PubMed |
| 11 | 9613987 | BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine. | Leuk Lymphoma | 1998 | https://conductscience.org/library/papers/9613987 | PubMed |
| 12 | 24531447 | Hairy cell leukemia: short review, today's recommendations and outlook. | Blood Cancer J | 2014 | https://conductscience.org/library/papers/24531447 | PubMed |
| 13 | 26813675 | Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia. | Blood | 2016 | https://conductscience.org/library/papers/26813675 | PubMed |
| 14 | 29891791 | TGF-β in T Cell Biology: Implications for Cancer Immunotherapy. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29891791 | PubMed |
| 15 | 23291630 | ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. | Nat Med | 2013 | https://conductscience.org/library/papers/23291630 | PubMed |
| 16 | 35893797 | Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35893797 | PubMed |
| 17 | 33882636 | Targeting the tumor microenvironment in chronic lymphocytic leukemia. | Haematologica | 2021 | https://conductscience.org/library/papers/33882636 | PubMed |
| 18 | 34943995 | Immunomodulatory Effects Associated with Cladribine Treatment. | Cells | 2021 | https://conductscience.org/library/papers/34943995 | PubMed |
| 19 | 2072745 | Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia. | Leukemia | 1991 | https://conductscience.org/library/papers/2072745 | PubMed |
| 20 | 9864168 | Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones. | Blood | 1999 | https://conductscience.org/library/papers/9864168 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42488707 | Tumor Plasticity and Microenvironmental Crosstalk as Drivers of Metastasis and Therapy Resistance. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42488707 | PubMed |
| 42113333 | Dynamic ecosystems of tumor drug resistance mechanisms: from molecular heterogeneity to systemic interventions. | Apoptosis | 2026 | https://conductscience.org/library/papers/42113333 | PubMed |
| 41789071 | Understanding hairy cell leukemia in the context of mature B-cell neoplasms: tumor microenvironment and extracellular vesicle contribution to disease pathogenesis. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789071 | PubMed |
| 39022363 | Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies. | ACS Pharmacol Transl Sci | 2024 | https://conductscience.org/library/papers/39022363 | PubMed |
| 38090582 | Broadening the horizon: potential applications of CAR-T cells beyond current indications. | Front Immunol | 2023 | https://conductscience.org/library/papers/38090582 | PubMed |
Genes49
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36968995
GET https://conductscience.org/api/papers/v1/36968995/references?page=2